NIKA PHARMACEUTICALS, INC. Business Development
NIKA PHARMACEUTICALS, INC. (NIKA) reported Business Development of $957.67 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2026-08-10
- NIKA PHARMACEUTICALS, INC. business development for the quarter ending 2026-06-30 was $0.00.
- NIKA PHARMACEUTICALS, INC. business development for the quarter ending 2026-03-31 was $957.67K, a 0.00% change year-over-year.
- NIKA PHARMACEUTICALS, INC. business development for the quarter ending 2025-12-31 was $0.00.
- NIKA PHARMACEUTICALS, INC. business development for the quarter ending 2025-09-30 was $0.00.
- NIKA PHARMACEUTICALS, INC. business development for fiscal 2025 was $957.67K, a 0.00% change from fiscal 2024.
- NIKA PHARMACEUTICALS, INC. business development for fiscal 2024 was $957.67K.
- NIKA PHARMACEUTICALS, INC. business development for fiscal 2022 was $3.00M.
| Period end | Business Development 3 month | Business Development 3 month as first filed | Business Development 6 month | Business Development 6 month as first filed | Business Development 9 month | Business Development 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $957.67K 10-Q · filed 2026-08-10 | $957.67K derived: sum of 3 quarters · filed 2026-08-10 | $957.67K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $957.67K 10-Q · filed 2026-05-12 | $957.67K derived: sum of 2 quarters · filed 2026-05-12 | $957.67K derived: sum of 3 quarters · filed 2026-05-12 | $957.67K derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $957.67K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $957.67K 10-Q · filed 2025-11-07 | $957.67K derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $957.67K 10-Q · filed 2025-08-14 | $957.67K derived: sum of 3 quarters · filed 2025-08-14 | $957.67K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2025-03-31 | $957.67K 10-Q · filed 2025-05-13 | $957.67K derived: sum of 2 quarters · filed 2025-05-13 | $957.67K derived: sum of 3 quarters · filed 2025-05-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $957.67K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-12 | $957.67K 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $957.67K 10-Q/A · filed 2024-11-01 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $3.00M derived: sum of 3 quarters · filed 2024-04-01 | $3.00M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $3.00M derived: sum of 2 quarters · filed 2023-10-31 | $3.00M 10-Q · filed 2023-10-31 | |||
| 2022-06-30 | $3.00M 10-Q · filed 2023-08-21 | $100.00K 10-Q · filed 2022-08-22 | $3.00M 10-Q · filed 2023-08-21 | $100.00K 10-Q · filed 2022-08-22 |